News & media
-
Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Second Quarter Results for 2022
-
Total number of shares and voting rights in Zealand Pharma at June 30, 2022
-
Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities
-
Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022
-
Zealand Pharma Presents Data from Phase 1 Trial of Dapiglutide at the 82nd Annual American Diabetes Association Scientific Sessions and Announces Dapiglutide to Move into Phase 2 Trial for Obesity
-
Zealand Pharma completes registration of capital increase
-
Zealand Pharma to Participate in Upcoming Investor Conferences
-
Zealand Pharma Announces Appointment of David M. Kendall, M.D., as Chief Medical Officer
-
Zealand Pharma announces directed issue and private placement corresponding to approx. 6.6 % of existing share capital
-
Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities
-
Zealand Pharma Announces Multiple Presentations at the 82nd Annual American Diabetes Association Scientific Sessions, Including Initial Clinical Data on GLP-1/GLP-2 Dual Agonist Dapiglutide
-
Zealand Pharma launches long-term incentive program for Zealand’s Corporate Management and employees for 2022
Corporate management
-
Adam Steensberg - President and Chief Executive Officer
-
Adam Steensberg - President and Chief Executive Officer
-
Adam Steensberg - President and Chief Executive Officer
-
Henriette Wennicke - Executive Vice President and Chief Financial Officer
-
Christina Sonnenborg Bredal - Executive Vice President and Chief People Officer
-
David Kendall - Executive Vice President, Research & Development and Chief Medical Officer
-
Ivan Møller - Executive Vice President and Chief Operating Officer
-
Utpal Singh - Executive Vice President and Chief Scientific Officer
-
Utpal Singh - Executive Vice President and Chief Scientific Officer
-
Steven Johnson - Executive Vice President, Chief Development Officer
-
Eric Cox - Executive Vice President, Chief Commercial Officer
Research and development
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
-
Lab photo
Sustainability
-
Morten Lagstrøm - ESG Officer
Logos and icons
-
)
Zealand Pharma Logo (RGB)
Stay up-to-date with the latest news from Zealand
Sign-up to receive press releases and company announcements directly to your inbox
Investor and Media contacts
